Bioxcel Therapeutics Inc

This study tested a new oral drug, BXCL701, given alongside the immunotherapy pembrolizumab in men with advanced prostate cancer that had stopped responding to standard treatments. The goal was to find a safe and effective dose and to see if the drug combination could help contro…

This study tested whether a medication film called BXCL501 can safely calm agitation episodes in people with dementia. Researchers enrolled 151 adults aged 65+ living in care facilities who experience agitation like kicking, biting, or flailing. Participants received either a low…

This study looked at what happens when people stop taking the medication Igalmi after using it for a week to treat severe agitation. It involved 29 adults with schizophrenia or bipolar disorder who took the drug as needed for agitation over 7 days, then were monitored for 3 days …

This study tested a medication called BXCL501 to see if it could safely and effectively calm episodes of agitation when used at home by adults with schizophrenia or bipolar disorder. In the second part of the trial, 452 participants used the medication as needed over 12 weeks at …